
A synthetic tetrapeptide studied in research into telomerase activity and cellular-senescence pathways in experimental models.
HPLC ≥99% research peptides · Southampton since 2019 · next-day mainland
FOXO4-DRI · Cellular & Senescence
Solent Peptides supplies FOXO4-DRI 10 mg as a defined research chemical from Southampton. Also listed as Proxofim. A D-retro-inverso peptide designed to interfere with FOXO4–p53 interaction, studied in cellular-senescence research models. Live UK price £175.50 (typical list £195.00). HPLC ≥99% at batch release. Laboratory use only — not a licensed medicine.
Solent Peptides supplies FOXO4-DRI 10 mg from Southampton as an HPLC ≥99% research chemical. Live UK price £175.50. Lot on the vial. Next-working-day mainland dispatch. Laboratory use only — not a licensed medicine. https://www.solentpeptides.co.uk/product/foxo4-dri
| Amount | Live UK price | Typical list | Product |
|---|---|---|---|
| 5 mg | £80.99 | £89.99 | FOXO4-DRI 5 mg |
| 10 mg | £175.50 | £195.00 | FOXO4-DRI 10 mg |
A D-retro-inverso peptide designed to interfere with FOXO4–p53 interaction, studied in cellular-senescence research models. Identity is published catalogue identifiers. FOXO4-DRI is offered for cellular-energy, senescence or related pathway work in experimental systems.
Catalogue sizes for FOXO4-DRI: 5 mg, 10 mg. This page is the 10 mg SKU at £175.50. Each size has its own product URL. Typical UK list is shown where we have a compare-at figure. Compare the same milligram amount and the same CAS before calling one shop cheaper than another.
FOXO4-DRI lots are released at ≥ 99% (HPLC) with identity confirmation. The lot number is on the vial. A paper certificate is not currently enclosed in every box. For a paid order, email sales@solentpeptides.co.uk with the order ID or the lot. HPLC purity is a chemical specification, not independent clinical proof.
Orders packed on a weekday before 14:00, payment cleared, typically reach most mainland UK addresses the next working day. No public walk-in counter. Guest checkout. sales@solentpeptides.co.uk · WhatsApp 07380 370380.
A D-retro-inverso peptide designed to interfere with FOXO4–p53 interaction, studied in cellular-senescence research models. Also catalogued as Proxofim. Solent Peptides supplies FOXO4-DRI (10 mg) as a defined lyophilised solid for non-clinical laboratory work, dispatched from Southampton after HPLC identity and purity checks. It is not a medicine, not a food, and not a cosmetic.
FOXO4-DRI is offered for cellular-energy, senescence or related pathway work in experimental systems. Documentation covers identity and purity, not biological effect.
Solent Peptides lists FOXO4-DRI 10 mg for laboratory research from Southampton at £175.50. HPLC ≥99%. Research use only.
5 mg £80.99; 10 mg £175.50. Live catalogue; promotions can change.
Yes. ≥ 99% (HPLC) at batch release. Lot on the vial.
No. FOXO4-DRI 10 mg is sold as a research chemical, not as a licensed medicine, and not for human or veterinary use.
Not currently as a printed insert in every carton. Email the order ID or vial lot for batch confirmation.

A synthetic tetrapeptide studied in research into telomerase activity and cellular-senescence pathways in experimental models.

A mitochondria-targeting tetrapeptide studied in research into cardiolipin interactions and mitochondrial-function pathways in experimental models.

A coenzyme studied in research into cellular-energy metabolism and sirtuin-pathway signalling in experimental models. Not a peptide.

500 mg NAD+ coenzyme (not a peptide) for cellular-energy and sirtuin-pathway laboratory work.